1Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med, 1999,340:207-214.
2Annane D, Sébille V, Troché G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA, 2000, 283: 1038-1045.
3Perla D, Marmorston J. Suprarenal cortical hormone and salt in the treatment of pneumonia and other severe infections. Endocrinology, 1940,27: 367-374.
4Hahn EO,Houser HB,Rammekamp CH,et al.Effect of cortisone on acute streptococcal infections and post-streptococcal complications. J Clin Invest,1951,30:274.
5Schumer.Steroids in the treatment of clinical septic shock. Ann Surg, 1976,183:333.
6Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med, 1987, 317:659-665.
7Bone RC, Fisher CJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med, 1987, 317:653-658.
8Luce JM,Montgomery AB,Marks JD,et al.Ineffectiveness of high-does methyprednisolone in preventing parenchymal lung and improving mortality in patients with septic shock. Am Rev Respir Dis,1988,138:62.
9McGowan JE,Chesney PJ, Crossley KB,et al. Guidelines for the use of systemic glucocorticoids in the management of selected infections. J Infect Dis, 1992, 165:1-13.
10Lefering R, Neugebauer EA.Steroid controversy in sepsis and septic shock: A meta-analysis. Crit Care Med, 1995, 23: 1294-1303.
